ELVN
Enliven Therapeutics, Inc.Company with tickers: ELVN
CIK
1672619
CUSIP
29337E102
Shares Outstanding
59,800,406
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-25 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Convert | 40,000 |
| 2026-03-25 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 40,000 |
| 2026-03-25 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Convert | 40,000 |
| 2026-03-17 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Convert | 5,000 |
| 2026-03-17 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 5,000 |
| 2026-03-17 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Convert | 5,000 |
| 2026-03-10 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Convert | 10,129 |
| 2026-03-10 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 10,129 |
| 2026-03-10 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Convert | 10,129 |
| 2026-03-09 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 29,871 |
| 2026-03-09 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Convert | 29,871 |
| 2026-03-09 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Convert | 29,871 |
| 2026-03-06 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 10,000 |
| 2026-02-17 | Heyman Richard A. | Director | Sell | 1,230 |
| 2026-02-17 | Heyman Richard A. | Director | Other | 123,673 |
| 2026-02-17 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Convert | 45,000 |
| 2026-02-17 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Convert | 45,000 |
| 2026-02-17 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell | 45,000 |
| 2026-02-12 | Gupta Rishi | Director | Award | 33,989 |
| 2026-02-12 | Garland J. Scott | Director | Award | 1,427 |
| 2026-02-12 | Ballal Rahul D. | Director | Award | 17,126 |
| 2026-02-12 | Patel Anish | CHIEF OPERATING OFFICER | Other | 215,011 |
| 2026-02-12 | Patel Anish | CHIEF OPERATING OFFICER | Award | 20,000 |
| 2026-02-12 | Patel Anish | CHIEF OPERATING OFFICER | Award | 120,000 |
| 2026-02-12 | Kunkel Lori Anne | Director | Award | 17,126 |
| 2026-02-12 | Heyman Richard A. | Director | Award | 19,234 |
| 2026-02-12 | Derynck Mika K | Director | Award | 17,126 |
| 2026-02-12 | Bauer Jake | Director | Award | 17,126 |
| 2026-02-12 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Award | 18,750 |
| 2026-02-12 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Award | 112,500 |
| 2026-02-12 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Other | 740,188 |
| 2026-02-12 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Award | 150,000 |
| 2026-02-12 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Award | 25,000 |
| 2026-02-12 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Award | 150,000 |
| 2026-02-12 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Award | 25,000 |
| 2026-02-06 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 5,000 |
| 2026-01-20 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 5,491 |
| 2026-01-20 | Heyman Richard A. | Director | Other | 123,673 |
| 2026-01-20 | Heyman Richard A. | Director | Sell | 512 |
| 2026-01-09 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 41,198 |
| 2026-01-09 | Heyman Richard A. | Director | Sell | 4,285 |
| 2026-01-09 | Patel Anish | CHIEF OPERATING OFFICER | Sell | 48,057 |
| 2026-01-08 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 7,500 |
| 2026-01-08 | Heyman Richard A. | Director | Other | 123,673 |
| 2026-01-08 | Heyman Richard A. | Director | Sell | 1,620 |
| 2026-01-07 | Garland J. Scott | Director | Award | 59,372 |
| 2026-01-07 | Garland J. Scott | Director | Other | 0 |
| 2025-12-22 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Convert | 13,000 |
| 2025-12-22 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Convert | 13,000 |
| 2025-12-19 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 5,000 |
| 2025-12-17 | Kunkel Lori Anne | Director | Other | 31,172 |
| 2025-12-17 | Kunkel Lori Anne | Director | Convert | 15,958 |
| 2025-12-17 | Kunkel Lori Anne | Director | Convert | 15,958 |
| 2025-12-11 | Fair Richard A. | Director, PRESIDENT AND CEO | Award | 875,000 |
| 2025-12-11 | Fair Richard A. | Director, PRESIDENT AND CEO | Other | 0 |
| 2025-12-08 | Patel Anish | CHIEF OPERATING OFFICER | Sell | 4,958 |
| 2025-11-19 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,008 |
| 2025-11-17 | Kintz Samuel | Director, PRESIDENT AND CEO | Sell | 12,500 |
| 2025-11-07 | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,054 |
| 2025-10-20 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,500 |
| 2025-10-17 | Kintz Samuel | Director, PRESIDENT AND CEO | Sell | 12,500 |
| 2025-10-07 | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,667 |
| 2025-09-29 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Convert | 3,250 |
| 2025-09-29 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Convert | 3,250 |
| 2025-09-29 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 |
| 2025-09-26 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 4,000 |
| 2025-09-26 | Kintz Samuel | Director, PRESIDENT AND CEO | Sell | 3,700 |
| 2025-09-23 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 1,500 |
| 2025-09-23 | Kintz Samuel | Director, PRESIDENT AND CEO | Sell | 2,800 |
| 2025-09-19 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 4,870 |
| 2025-09-19 | Kintz Samuel | Director, PRESIDENT AND CEO | Sell | 1,000 |
| 2025-09-17 | Kintz Samuel | Director, PRESIDENT AND CEO | Sell | 5,000 |
| 2025-09-08 | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,667 |
| 2025-08-27 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Convert | 3,250 |
| 2025-08-27 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,250 |
| 2025-08-27 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Convert | 3,250 |
| 2025-08-21 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 7,500 |
| 2025-08-19 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 5,000 |
| 2025-08-19 | Kintz Samuel | Director, PRESIDENT AND CEO | Sell | 590 |
| 2025-08-18 | Kintz Samuel | Director, PRESIDENT AND CEO | Sell | 10,393 |
| 2025-08-07 | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,262 |
| 2025-07-28 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,185 |
| 2025-07-28 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Convert | 3,250 |
| 2025-07-28 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Convert | 3,250 |
| 2025-07-21 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 11,924 |
| 2025-07-17 | Kintz Samuel | Director, PRESIDENT AND CEO | Sell | 4,150 |
| 2025-07-10 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Convert | 1,000 |
| 2025-07-10 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 1,000 |
| 2025-07-10 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Convert | 1,000 |
| 2025-07-07 | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,362 |
| 2025-06-27 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,052 |
| 2025-06-27 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Convert | 3,250 |
| 2025-06-27 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Convert | 3,250 |
| 2025-06-20 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 12,500 |
| 2025-06-17 | Kintz Samuel | Director, PRESIDENT AND CEO | Sell | 10,502 |
| 2025-06-13 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Convert | 3,000 |
| 2025-06-13 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell | 3,000 |
| 2025-06-13 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Convert | 3,000 |
| 2025-06-09 | Patel Anish | CHIEF OPERATING OFFICER | Sell | 6,607 |
| 2025-06-03 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell | 7,500 |